证券记录 · 已归档季度
DXCM
DexCom, Inc. · Healthcare · Medical - Devices
21被追踪持有人
n/aΔ持有人
52.99M持有股份
$6.01B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 166 | +2 | 299.42M | $20.12B | +7 | −7 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | n/a |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | n/a | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | n/a | n/a |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | n/a |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | n/a | −2 |
| Q2 2024 | 21 | n/a | 52.99M | $6.01B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 15.33M | n/a | $1.74B | 1.4% | n/c | 1 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (被动) | 9.72M | n/a | $1.10B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 8.31M | n/a | $942.19M | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (被动) | 5.39M | n/a | $611.04M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.33M | n/a | $604.48M | 0.1% | n/c | 1 | SEC ↗ ×12 |
| 6 | T. Rowe Price ✦ | 3.45M | n/a | $391.15M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Tiger Global Management ✦ | 1.15M | n/a | $130.71M | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 773.87K | n/a | $87.74M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 752.32K | n/a | $85.30M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 10 | Citadel Advisors ✦ | 727.88K | n/a | $82.53M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 11 | Renaissance Technologies ✦ | 462.57K | n/a | $52.45M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 389.00K | n/a | $44.10M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 351.31K | n/a | $39.83M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 14 | Bridgewater Associates ✦ | 347.32K | n/a | $39.38M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Soros Fund Management ✦ | 166.80K | n/a | $18.91M | 0.6% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 85.02K | n/a | $9.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Millennium Management ✦ | 64.49K | n/a | $7.31M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 54.97K | n/a | $6.23M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 52.00K | n/a | $5.90M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 47.88K | n/a | $5.43M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 35.74K | n/a | $4.05M | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 15.50K 股份, $973 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 28
Stern Sadie
Officer · 2.56K 股 · $220,975
Sep 15
AUGUSTINOS NICHOLAS
Director · 6.54K 股 · $549,538
Sep 15
Brown Michael Jon
Officer · 1.70K 股 · $142,868
Sep 14
AUGUSTINOS NICHOLAS
Director · 1.55K 股 · $130,231
Sep 10
Sylvain Jereme M
Officer · 3.64K 股 · $302,936
Aug 27
Stern Sadie
Officer · 2.56K 股 · $226,669
Aug 20
SAYER KEVIN R
Officer, Director · 19.31K 股 · $1.73M
Aug 20
SAYER KEVIN R
Officer, Director · 97 股 · $8,867
Aug 20
SAYER KEVIN R
Officer, Director · 7.35K 股 · $667,332
Aug 14
Brown Michael Jon
Officer · 1.70K 股 · $156,281
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据